Aethlon Medical INC Schedule 13G passive stakes
Filed when an investor crosses five percent without intending to seek control — the passive counterpart to a 13D.
NASDAQ
A Schedule 13G filing reveals passive ownership of Aethelon Medical Inc. common stock by Mitchell P. Kopin, Daniel B. Asher, and Intracoastal Capital LLC.
NASDAQ
Armistice Capital, LLC and Steven Boyd have jointly reported a beneficial ownership of 4.99% of Aethlon Medical, Inc.'s common stock as of March 31, 2026.
NASDAQ
Armistice Capital, LLC and Steven Boyd have reported a beneficial ownership of 4.99% in Aethlon Medical Inc., a reduction that places their stake below the 5% threshold.
NASDAQ
Ikarian Capital, LLC and Neil Shahrestani have reported a 2.0% beneficial ownership stake in Aethlon Medical, Inc., totaling 15,366 shares.
NASDAQ
Alumni Capital LP and its affiliates have reported a 9.58% beneficial ownership stake in Aethlon Medical Inc., primarily through a Securities Purchase Agreement and warrants.
NASDAQ
Intracoastal Capital LLC, along with Mitchell P. Kopin and Daniel B. Asher, reported a 7.7% beneficial ownership stake in Aethlon Medical, Inc. as of September 10, 2025.
NASDAQ
Armistice Capital, LLC and Steven Boyd have disclosed a beneficial ownership of 7.16% in Aethlon Medical Inc.'s common stock.
NASDAQ
Armistice Capital, LLC and Steven Boyd have jointly reported a beneficial ownership of 9.99% in Aethlon Medical Inc.'s common stock as of March 31, 2025.
NASDAQ
Investment firm Ikarian Capital, LLC and its controller Neil Shahrestani have disclosed a passive 8.7% beneficial ownership stake in Aethlon Medical, Inc., totaling 1,229,285 shares.